Clinical Trials Logo

Clinical Trial Summary

In literature, it has been reported that exercise capacity decreases in single-ventricle patients undergoing Fontan Procedure due to various factors related to surgery and underlying cardiac anomaly. Cardiopulmonary exercise test (CPET) was generally used to evaluate exercise capacity in children and adults with fontan circulation. The fact that CPET requires a clinically expert team and equipment and is more expensive does not always make it possible to perform routine cardiopulmonary exercise testing. In some cases, field tests evaluating submaximal and maximal exercise capacity may be more practical than cardiopulmonary exercise testing. Therefore, in this study, it is aimed to evaluate the exercise capacity of Fontan patients with 6-minute walking test and incremental shuttle walk test and to compare vital signs during the tests.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05063903
Study type Observational
Source Hacettepe University
Contact Haluk Tekerlek
Phone +90-535-591-5009
Email [email protected]
Status Recruiting
Start date September 20, 2021
Completion date April 18, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05034354 - Virtual Remote Physiological Monitoring Program of Children With Heart Disease N/A
Recruiting NCT03119090 - Fontan Imaging Biomarkers (FIB) Study
Recruiting NCT04956952 - Enhanced External Counterpulsation in Patients With Fontan Circulation N/A
Not yet recruiting NCT04017494 - Validation of Cardiac Magnetic Resonance Sequences in Patients With Single Ventricles
Recruiting NCT04106479 - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Not yet recruiting NCT05011565 - Hemodynamic, Vascular and Muscular Parameters of Exercise Capacity in Single-Ventricle Patients With Fontan Procedure
Active, not recruiting NCT03481985 - The Effect of Fontan Fenestration Closure on Hepatic Stiffness
Completed NCT03088345 - Early Use of Vasopressin in Post-Fontan Management Phase 2/Phase 3
Active, not recruiting NCT03470428 - Clinical Characteristics and Associations of the "Good Fontan" Patient
Recruiting NCT04785482 - The PaTHS Descriptive Correlational Longitudinal Study
Not yet recruiting NCT03997097 - Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease Phase 3
Withdrawn NCT01149603 - The Destination Therapy Evaluation for Failing Fontan Study N/A
Recruiting NCT04467671 - Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts Phase 2
Completed NCT03339466 - Inspiratory Muscle Therapy in Subjects With Fontan Circulations N/A
Active, not recruiting NCT03263312 - Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient N/A
Completed NCT04613934 - Redesigning the Care Journey of Patients With Single-ventricle Congenital Heart Disease
Recruiting NCT04901975 - Fibrosis and the Fontan Phase 1/Phase 2
Recruiting NCT03404258 - ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis
Suspended NCT02975999 - Use of Vasopressin Following the Fontan Operation Phase 2/Phase 3
Terminated NCT03575572 - Colchicine in Postoperative Fontan Patients Phase 2/Phase 3